These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 21937643

  • 1. Hepatocytes traffic and export hepatitis B virus basolaterally by polarity-dependent mechanisms.
    Bhat P, Snooks MJ, Anderson DA.
    J Virol; 2011 Dec; 85(23):12474-81. PubMed ID: 21937643
    [Abstract] [Full Text] [Related]

  • 2. Effect of nucleoside analogue therapy on duck hepatitis B viral replication in hepatocytes and bile duct epithelial cells in vivo.
    Nicoll A, Locarnini S, Chou ST, Smallwood R, Angus P.
    J Gastroenterol Hepatol; 2000 Mar; 15(3):304-10. PubMed ID: 10764033
    [Abstract] [Full Text] [Related]

  • 3. Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier.
    Sprinzl MF, Oberwinkler H, Schaller H, Protzer U.
    J Virol; 2001 Jun; 75(11):5108-18. PubMed ID: 11333892
    [Abstract] [Full Text] [Related]

  • 4. Characterization of age- and dose-related outcomes of duck hepatitis B virus infection.
    Jilbert AR, Botten JA, Miller DS, Bertram EM, Hall PM, Kotlarski J, Burrell CJ.
    Virology; 1998 May 10; 244(2):273-82. PubMed ID: 9601498
    [Abstract] [Full Text] [Related]

  • 5. Viral and cellular determinants involved in hepadnaviral entry.
    Glebe D, Urban S.
    World J Gastroenterol; 2007 Jan 07; 13(1):22-38. PubMed ID: 17206752
    [Abstract] [Full Text] [Related]

  • 6. Duck hepatitis B virus replication in primary bile duct epithelial cells.
    Lee JY, Culvenor JG, Angus P, Smallwood R, Nicoll A, Locarnini S.
    J Virol; 2001 Aug 07; 75(16):7651-61. PubMed ID: 11462037
    [Abstract] [Full Text] [Related]

  • 7. Primary Duck Hepatocyte Culture and Duck Hepatitis B Virus Infection Model.
    Li J, Tong S.
    Methods Mol Biol; 2024 Aug 07; 2837():11-22. PubMed ID: 39044071
    [Abstract] [Full Text] [Related]

  • 8. Heterologous replacement of the supposed host determining region of avihepadnaviruses: high in vivo infectivity despite low infectivity for hepatocytes.
    Dallmeier K, Schultz U, Nassal M.
    PLoS Pathog; 2008 Dec 07; 4(12):e1000230. PubMed ID: 19057662
    [Abstract] [Full Text] [Related]

  • 9. Spread of hepatitis B viruses in vitro requires extracellular progeny and may be codetermined by polarized egress.
    Funk A, Hohenberg H, Mhamdi M, Will H, Sirma H.
    J Virol; 2004 Apr 07; 78(8):3977-83. PubMed ID: 15047813
    [Abstract] [Full Text] [Related]

  • 10. Kinetics of duck hepatitis B virus infection following low dose virus inoculation: one virus DNA genome is infectious in neonatal ducks.
    Jilbert AR, Miller DS, Scougall CA, Turnbull H, Burrell CJ.
    Virology; 1996 Dec 15; 226(2):338-45. PubMed ID: 8955053
    [Abstract] [Full Text] [Related]

  • 11. [Inhibition of binding peptides on replication of duck hepatitis B virus].
    Jia HY, Chen Z, Zhou LF, Chen F, Zhu HH, Liu JH, Xu XY.
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2005 Mar 15; 34(2):116-20. PubMed ID: 15812883
    [Abstract] [Full Text] [Related]

  • 12. Covalently closed circular DNA is the predominant form of duck hepatitis B virus DNA that persists following transient infection.
    Le Mire MF, Miller DS, Foster WK, Burrell CJ, Jilbert AR.
    J Virol; 2005 Oct 15; 79(19):12242-52. PubMed ID: 16160150
    [Abstract] [Full Text] [Related]

  • 13. Competition in vivo between a cytopathic variant and a wild-type duck hepatitis B virus.
    Lenhoff RJ, Luscombe CA, Summers J.
    Virology; 1998 Nov 10; 251(1):85-95. PubMed ID: 9813205
    [Abstract] [Full Text] [Related]

  • 14. Antiviral therapy with entecavir combined with post-exposure "prime-boost" vaccination eliminates duck hepatitis B virus-infected hepatocytes and prevents the development of persistent infection.
    Miller DS, Boyle D, Feng F, Reaiche GY, Kotlarski I, Colonno R, Jilbert AR.
    Virology; 2008 Apr 10; 373(2):329-41. PubMed ID: 18206204
    [Abstract] [Full Text] [Related]

  • 15. Alternative methods for validation of cell culture infection with duck hepatitis B virus.
    Sauerbrei A, Schacke M, Schultz U, Egerer R, Merkle I, Glebe D, Gerlich W, Wutzler P.
    J Virol Methods; 2005 Nov 10; 129(2):178-85. PubMed ID: 16002155
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of duck hepatitis B virus infection of liver cells by combined treatment with viral e antigen and carbohydrates.
    Maenz C, Loscher C, Iwanski A, Bruns M.
    J Gen Virol; 2008 Dec 10; 89(Pt 12):3016-3026. PubMed ID: 19008388
    [Abstract] [Full Text] [Related]

  • 17. Infection of ducklings with virus particles containing linear double-stranded duck hepatitis B virus DNA: illegitimate replication and reversion.
    Yang W, Summers J.
    J Virol; 1998 Nov 10; 72(11):8710-7. PubMed ID: 9765413
    [Abstract] [Full Text] [Related]

  • 18. Glycine decarboxylase mediates a postbinding step in duck hepatitis B virus infection.
    Li J, Tong S, Lee HB, Perdigoto AL, Spangenberg HC, Wands JR.
    J Virol; 2004 Feb 10; 78(4):1873-81. PubMed ID: 14747552
    [Abstract] [Full Text] [Related]

  • 19. Rapid production of neutralizing antibody leads to transient hepadnavirus infection.
    Zhang YY, Summers J.
    J Virol; 2004 Feb 10; 78(3):1195-201. PubMed ID: 14722274
    [Abstract] [Full Text] [Related]

  • 20. Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks.
    Fourel I, Cullen JM, Saputelli J, Aldrich CE, Schaffer P, Averett DR, Pugh J, Mason WS.
    J Virol; 1994 Dec 10; 68(12):8321-30. PubMed ID: 7966625
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.